Drug Delivery Business4d
Dexcom CGM now connects with Novo Nordisk smart insulin pens, 15-day CGM shows promise
Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...
Novo Nordisk (NVO): Among the Best Diabetes Stocks to Buy According to Billionaires
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade)
Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...
Market Inference13d
Here's What You May Have Missed About Novo Nordisk A/S(NVO)
One of the losers of today's trading session was Novo Nordisk A/S. Shares of the Pharmaceutical company plunged -9.8%, and some investors may be wondering if its price of $78.63 would make a good ...
South African Competition Commission probes Novo Nordisk and Sanofi over insulin pen market
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about ...
pulmonologyadvisor14d
Novo Nordisk Provides Direct-to-Patient Delivery Option for Wegovy
Novo Nordisk is providing direct-to-patient delivery of Wegovy ... FDA-approved Wegovy at a reduced cost in our high-quality pen.” For eligible patients, health care providers can send Wegovy ...
Stockhouse14d
ROSEN, A LEADING AND RANKED FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
New York, New York--(Newsfile Corp. - March 9, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 ...
Healio16d
NovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain
Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...
FiercePharma16d
With blood and growth disorder bids panning out, Novo Nordisk plots path to rare disease leadership: exec
From 'back burner' to full throttle Novo Nordisk's rare disease ambitions first began to shift when Lars Fruergaard Jørgensen donned the mantle of CEO in 2017. “One of the intuitions that Lars ...
clinicaladvisor.com17d
Novo Nordisk Provides Direct-to-Patient Delivery Option for Wegovy
Novo Nordisk is providing direct-to-patient delivery ... FDA-approved Wegovy at a reduced cost in our high-quality pen.” For eligible patients, health care providers can send Wegovy ...
The Financial Express17d
Novo Nordisk to launch new therapies in blood and growth disorders after success in diabetes and obesity
Novo Nordisk has become a global sensation with ... disease into innovative medicines and delivery systems, like insulin pens. The company’s disease portfolio includes diabetes, obesity, and ...
Yahoo Finance17d
'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen
Novo Nordisk (NVO) is not concerned by the ongoing ... dedicated to producing GLP-1 injectable pens. Novo is also already in North Carolina, with a $2.5 billion API production site, and is ...